CN110193010A - A kind of preparation and preparation method thereof for alleviating schneiderian membrane symptom - Google Patents

A kind of preparation and preparation method thereof for alleviating schneiderian membrane symptom Download PDF

Info

Publication number
CN110193010A
CN110193010A CN201910532144.4A CN201910532144A CN110193010A CN 110193010 A CN110193010 A CN 110193010A CN 201910532144 A CN201910532144 A CN 201910532144A CN 110193010 A CN110193010 A CN 110193010A
Authority
CN
China
Prior art keywords
preparation
glycyrrhizin
alleviating
schneiderian membrane
symptom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910532144.4A
Other languages
Chinese (zh)
Inventor
李春江
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jilin Huan Biological Science And Technology Co Ltd
Original Assignee
Jilin Huan Biological Science And Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jilin Huan Biological Science And Technology Co Ltd filed Critical Jilin Huan Biological Science And Technology Co Ltd
Priority to CN201910532144.4A priority Critical patent/CN110193010A/en
Publication of CN110193010A publication Critical patent/CN110193010A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants

Abstract

A kind of preparation and preparation method thereof for alleviating schneiderian membrane symptom, the component including mass percent: pure water 10%~99%, glycerol 0.1%~20%, glycyrrhizin salt 0.1%~10%, Beta glucan 0.1%~5%, sodium chloride 0.1%~5%.The invention has the advantages that the 1, present invention can make schneiderian membrane keep wet, alleviates the schneiderian membrane swelling of lesser degree or mitigate stimulated schneiderian membrane swelling.Using nasal spray according to the present invention, there is the dry sensation occurred when using the nasal spray containing hormone, antihistamine drug, leukotriene antagonist etc. in smaller probability;2, because preparation provided by the invention does not contain any forbidden amphetamine, so having no toxic side effect, being safe and reliable;3, preparation provided by the present invention can be used in conjunction with the nasal spray containing hormone, antihistamine drug, leukotriene antagonist etc..In order to reduce using the nasal spray bring side effect containing hormone, antihistamine drug, leukotriene antagonist etc., their dosage can be reduced more than half.

Description

A kind of preparation and preparation method thereof for alleviating schneiderian membrane symptom
Technical field
The invention belongs to preparation for treating rhinitis field, specifically a kind of preparation for alleviating schneiderian membrane symptom and its preparation side Method.
Background technique
In common cold, allergen allergic rhinitis or other rhinitis (rhinitides), schneiderian membrane is subjected to swelling.So far Until the present, local use hormone (for example, glucocorticoid etc.), antihistamine drug usually in the form of nasal drop or nasal spray (for example, Loratadine, Desloratadine etc.), leukotriene antagonist etc. are treated, to realize the mitigation of mucous membrane swelling.So And the above drug has many undesirable side effects because of absorption and may cause palpitaition and respiratory disorder.In addition, they Schneiderian membrane is set to dry out, and when chronic administration, in fact it could happen that the permanent damage of nasal epithelial.This pharmacological dependence is led The rhinitis of cause is referred to as rhinitis medicamentosa.In recent years, occur hormone-free, anti-based on sea salt and/or common saline solution The nasal spray of histamine drug, leukotriene antagonist.They do not have acute pharmacological action to schneiderian membrane, but by keeping mucous membrane wet clear It is clean that mucous membrane can be alleviated and thus alleviate symptom (especially after applying for several times).But due to the residence time of solution compared with It is short, solution must be fairly frequently applied, and alleviation degree is often insufficient when disease is serious.
Summary of the invention
For existing nasal spray there are a variety of shortcomings, the present invention provides a kind of preparation for alleviating schneiderian membrane symptom, this hair Bright purpose, which is to provide, has relaxation effect to schneiderian membrane compared with known product, but it not will lead to use and contains hormone (example Such as, glucocorticoid etc.), antihistamine drug (for example, Loratadine, Desloratadine etc.), leukotriene antagonist etc. product When the dependence and side effect that will appear, to solve defect in the prior art.
The present invention is achieved by the following technical programs:
A kind of preparation for alleviating schneiderian membrane symptom, the component including mass percent: pure water 10%~99%, glycerol 0.1%~20%, glycyrrhizin salt 0.1%~10%, Beta glucan 0.1%~5%, sodium chloride 0.1%~5%.
A kind of preparation for alleviating schneiderian membrane symptom as described above, the component including mass percent: pure water 90%~ 98%, glycerol 0.5%~5%, glycyrrhizin salt 0.5%~5%, Beta glucan 0.1%~2%, sodium chloride 0.5%~ 2%.
A kind of preparation for alleviating schneiderian membrane symptom as described above, the glycyrrhizin salt is glycyrrhizin disodium, sweet It is one sodium of oxalic acid glycosides, glycyrrhizin monoamine, glycyrrhizin diamines, one potassium of glycyrrhizin, glycyrrhizin dipotassium, glycyrrhizin salt, sweet Oxalic acid glycosides trisodium, glycyrrhizin tripotassium, any one or any two or more of glycyrrhizin triamine are mixed with arbitrary proportion.
A kind of preparation for alleviating schneiderian membrane symptom as described above, the present invention, can be by medicine of the present invention by pH controlling agent The pH value of product is adjusted to the pH of pharmaceutical formulation.
A kind of preparation for alleviating schneiderian membrane symptom as described above, the pH controlling agent are sodium hydroxide, sodium phosphate, lemon Any of them of lemon acid sodium, phosphate, citrate buffer agent.
A kind of preparation for alleviating schneiderian membrane symptom as described above, osmotic pressure of the invention is towards slight hyperosmosis tune Section.
A kind of preparation for alleviating schneiderian membrane symptom as described above, osmotic pressure of the invention are 400mosmol.
A kind of preparation for alleviating schneiderian membrane symptom as described above, osmotic pressure adjusting group of the invention are divided into glucose, mountain Pears alcohol, mannitol, xylitol any of them any two or more are mixed with arbitrary proportion.
A kind of preparation method of preparation that alleviating schneiderian membrane symptom, characterized by the following steps:
Step 1: glycerol, sodium chloride is added into pure water under stirring, is stirred until homogeneous dispersed;
Step 2: step 1 acquired solution is stirred, addition licorice, beta glucan into it, homogeneous stirring, Discharging sterilizes to get the preparation of the alleviation schneiderian membrane symptom.
A kind of preparation method of preparation for alleviating schneiderian membrane symptom as described above, the present invention can be made into drops, spray, Any one dosage form of irrigation.
The invention has the advantages that
1, preparation provided by the present invention " can alleviate schneiderian membrane symptom ", in particular, being that schneiderian membrane is instigated to keep wet Profit alleviates the schneiderian membrane swelling of lesser degree or mitigates stimulated schneiderian membrane swelling.Using nasal spray according to the present invention, Smaller probability occur using containing hormone (for example, glucocorticoid etc.), antihistamine drug (for example, Loratadine, chlorine thunder he It is fixed etc.), the nasal spray of leukotriene antagonist etc. when the dry sensation that occurs.
2, because preparation provided by the invention does not contain any forbidden amphetamine (such as heavy metal, hormone, toxin, non-permitted chemistry Substance etc.), so having no toxic side effect, being safe and reliable.
3, preparation provided by the present invention can with contain hormone (such as glucocorticoid etc.), antihistamine drug (example Such as, Loratadine, Desloratadine etc.), the nasal spray of leukotriene antagonist etc. is used in conjunction with.Contain hormone to reduce use The spray of (for example, glucocorticoid etc.), antihistamine drug (for example, Loratadine, Desloratadine etc.), leukotriene antagonist etc. Their dosage can be reduced more than half by nose agent bring side effect.
Specific embodiment
In order to make the object, technical scheme and advantages of the embodiment of the invention clearer, below in conjunction with the embodiment of the present invention, Technical scheme in the embodiment of the invention is clearly and completely described, it is clear that described embodiment is the present invention one Divide embodiment, instead of all the embodiments.Based on the embodiments of the present invention, those of ordinary skill in the art are not making Every other embodiment obtained, shall fall within the protection scope of the present invention under the premise of creative work.
Embodiment 1
A kind of preparation for alleviating schneiderian membrane symptom, said preparation includes the component of following mass percent: glycerol 1%, Radix Glycyrrhizae Sour glycosides salt 2%, Beta glucan 1%, sodium chloride 0.9%, remaining ingredient are pure water.
Follow the steps below operation:
Step 1: being added glycerol, sodium chloride into pure water under stirring, be stirred until homogeneous dispersed, spare;
Step 2: glycyrrhizin salt, beta glucan, constant temperature is added in step 1 acquired solution under stirring into it Homogeneous stirring, it is spare;
Step 3: step 2 acquired solution is sterilized;
Step 4: step 3 acquired solution is bottled.
Embodiment 2
A kind of preparation for alleviating schneiderian membrane symptom, said preparation includes the component of following mass percent: glycerol 2%, Radix Glycyrrhizae Sour glycosides salt 2%, Beta glucan 1%, sodium chloride 0.9%, remaining ingredient are pure water.
Follow the steps below operation:
Step 1: being added glycerol, sodium chloride into pure water under stirring, be stirred until homogeneous dispersed, spare;
Step 2: glycyrrhizin salt, beta glucan, constant temperature is added in step 1 acquired solution under stirring into it Homogeneous stirring, it is spare;
Step 3: step 2 acquired solution is sterilized;
Step 4: step 3 acquired solution is bottled.
The preparation of the present invention for alleviating schneiderian membrane symptom is transparent or close to transparent liquid, there is faint special gas Taste, pH
Value is 5.5~7.4, which should be sealed in a cool and dry place, can be stablized storage 1 year or more.This goes wrinkle tight Also dried frozen aquatic products further can be made by means such as freeze-dryings in skin liquid, and are restored to liquid condition by being dissolved in aqueous solution and make With.It may be made as the products such as drops, spray and/or irrigation.
Confirmatory experiment 1
Experimental subjects: the age 20-70 years old crowd, the male and female for selecting schneiderian membrane to have different stimulated symptom have 17 altogether Example.
Experimental method: for the drop of preparation provided by daily Example 1 in nasal membrane position 3~5 times, 5 days are a treatment Journey.
Criterion of therapeutical effect: 1, cure: nasal membrane irritation completely disappears;2, effective: nasal membrane irritation is obvious Alleviate;3, effectively: alleviating nasal membrane irritation part;3, invalid: unchanged before and after use.
Using effect is as follows:
Confirmatory experiment 2:
Experimental subjects: the age 20-70 years old crowd, the male and female for selecting schneiderian membrane to have different stimulated symptom have 24 altogether Example.
Experimental method: for the drop of preparation provided by daily Example 2 in nasal membrane position 3~5 times, 5 days are a treatment Journey.
Criterion of therapeutical effect: 1, cure: nasal membrane irritation completely disappears;2, effective: nasal membrane irritation is obvious Alleviate;3, effectively: alleviating nasal membrane irritation part;3, invalid: unchanged before and after use.
Using effect is as follows:
According to verifying
Finally it should be noted that: the above embodiments are merely illustrative of the technical scheme of the present invention and are not intended to be limiting thereof, to the greatest extent Invention is explained in detail referring to above-described embodiment for pipe, it should be understood by those ordinary skilled in the art that: still It can be with modifications or equivalent substitutions are made to specific embodiments of the invention, and without departing from any of spirit and scope of the invention Modification or equivalent replacement, are intended to be within the scope of the claims of the invention.
The preparation of the present invention for alleviating schneiderian membrane symptom is transparent or close to transparent liquid, there is faint special gas Taste, pH value are 5.5~7.4, which should be sealed in a cool and dry place, can be stablized storage 1 year or more.This removes wrinkle Firm liquid Also dried frozen aquatic products further can be made by means such as freeze-dryings, and be restored to liquid condition use by being dissolved in aqueous solution.? It can be made into the products such as drops, spray and/or irrigation.
Finally, it should be noted that the above embodiments are merely illustrative of the technical solutions of the present invention, rather than its limitations;Although Present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that: it still may be used To modify the technical solutions described in the foregoing embodiments or equivalent replacement of some of the technical features; And these are modified or replaceed, technical solution of various embodiments of the present invention that it does not separate the essence of the corresponding technical solution spirit and Range.

Claims (10)

1. a kind of preparation for alleviating schneiderian membrane symptom, it is characterised in that: the component including mass percent:: pure water 10%~ 99%, glycerol 0.1%~20%, glycyrrhizin salt 0.1%~10%, Beta glucan 0.1%~5%, sodium chloride 0.1%~ 5%.
2. a kind of preparation for alleviating schneiderian membrane symptom according to claim 1, it is characterised in that: including mass percent Component: pure water 90%~98%, glycerol 0.5%~5%, glycyrrhizin salt 0.5%~5%, Beta glucan 0.1%~ 2%, sodium chloride 0.5%~2%.
3. a kind of preparation for alleviating schneiderian membrane symptom according to claim 1, it is characterised in that: the glycyrrhizin salt For glycyrrhizin disodium, one sodium of glycyrrhizin, glycyrrhizin monoamine, glycyrrhizin diamines, one potassium of glycyrrhizin, glycyrrhizin two Potassium, glycyrrhizin salt, glycyrrhizin trisodium, glycyrrhizin tripotassium, glycyrrhizin triamine it is any one or any two or more It is mixed with arbitrary proportion.
4. a kind of preparation for alleviating schneiderian membrane symptom according to claim 1, it is characterised in that: the present invention is controlled by pH The pH value of drug of the present invention can be adjusted to the pH of pharmaceutical formulation by agent.
5. a kind of preparation for alleviating schneiderian membrane symptom according to claim 4, it is characterised in that: the pH controlling agent is Any of them of sodium hydroxide, sodium phosphate, sodium citrate, phosphate, citrate buffer agent.
6. a kind of preparation for alleviating schneiderian membrane symptom according to claim 1, it is characterised in that: osmotic pressure court of the invention It is adjusted to slight hyperosmosis.
7. a kind of preparation for alleviating schneiderian membrane symptom according to claim 6, it is characterised in that: osmotic pressure of the invention is 400mosmol。
8. a kind of preparation for alleviating schneiderian membrane symptom according to claim 1, it is characterised in that: osmotic pressure tune of the invention Section group is divided into glucose, sorbierite, mannitol, xylitol any of them or any two or more is mixed with arbitrary proportion.
9. a kind of preparation method for the preparation for alleviating schneiderian membrane symptom, characterized by the following steps:
Step 1: glycerol, sodium chloride is added into pure water under stirring, is stirred until homogeneous dispersed;
Step 2: step 1 acquired solution is stirred, addition licorice, beta glucan into it, homogeneous stirring, out Material sterilizes to get the preparation of the alleviation schneiderian membrane symptom.
10. a kind of preparation method of preparation for alleviating schneiderian membrane symptom according to claim 9, it is characterised in that: this hair It is bright to can be made into any one dosage form of drops, spray, irrigation.
CN201910532144.4A 2019-06-19 2019-06-19 A kind of preparation and preparation method thereof for alleviating schneiderian membrane symptom Pending CN110193010A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910532144.4A CN110193010A (en) 2019-06-19 2019-06-19 A kind of preparation and preparation method thereof for alleviating schneiderian membrane symptom

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910532144.4A CN110193010A (en) 2019-06-19 2019-06-19 A kind of preparation and preparation method thereof for alleviating schneiderian membrane symptom

Publications (1)

Publication Number Publication Date
CN110193010A true CN110193010A (en) 2019-09-03

Family

ID=67754742

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910532144.4A Pending CN110193010A (en) 2019-06-19 2019-06-19 A kind of preparation and preparation method thereof for alleviating schneiderian membrane symptom

Country Status (1)

Country Link
CN (1) CN110193010A (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102836176A (en) * 2012-09-20 2012-12-26 滨海金桥医药科技(北京)有限公司 Drug combination for treating allergic rhinitis or asthma as well as preparation method and application of same
EP2857068A1 (en) * 2013-10-04 2015-04-08 Aboca S.p.A. Societa' Agricola Fractions of liquorice extracts depleted of glycyrrhizic acid and uses thereof
CN105902555A (en) * 2016-06-22 2016-08-31 张波 Novel nasal irrigation composition and preparation method thereof
CN106166273A (en) * 2016-08-30 2016-11-30 王晓琴 A kind of otorhinolaryngology nursing medicine for external use and preparation method thereof
CN106902075A (en) * 2017-02-23 2017-06-30 任君刚 A kind of water sensitive adhesiveness ointment based on non-aqueous techniques and preparation method thereof
CN110279695A (en) * 2019-08-07 2019-09-27 北京博达绿洲医药科技研究有限公司 It is a kind of to treat pharmaceutical compositions of cold symptoms such as runny nose, nasal obstruction and its preparation method and application

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102836176A (en) * 2012-09-20 2012-12-26 滨海金桥医药科技(北京)有限公司 Drug combination for treating allergic rhinitis or asthma as well as preparation method and application of same
EP2857068A1 (en) * 2013-10-04 2015-04-08 Aboca S.p.A. Societa' Agricola Fractions of liquorice extracts depleted of glycyrrhizic acid and uses thereof
CN105902555A (en) * 2016-06-22 2016-08-31 张波 Novel nasal irrigation composition and preparation method thereof
CN106166273A (en) * 2016-08-30 2016-11-30 王晓琴 A kind of otorhinolaryngology nursing medicine for external use and preparation method thereof
CN106902075A (en) * 2017-02-23 2017-06-30 任君刚 A kind of water sensitive adhesiveness ointment based on non-aqueous techniques and preparation method thereof
CN110279695A (en) * 2019-08-07 2019-09-27 北京博达绿洲医药科技研究有限公司 It is a kind of to treat pharmaceutical compositions of cold symptoms such as runny nose, nasal obstruction and its preparation method and application

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
XIAO-LAN LI: "Antioxidant Status and Immune Activity of Glycyrrhizin in Allergic Rhinitis Mice", 《INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES》 *

Similar Documents

Publication Publication Date Title
US6080783A (en) Method and composition for delivering zinc to the nasal membrane
EP0053754B1 (en) Drug for antagonizing snore, and method for its application
EP2613793B1 (en) Nasal spray
CN109953923A (en) A kind of hair eyelashes growth-promoting media containing schizophyllan, Radix Rehmanniae and pine extract
CN104622855A (en) Oral solution containing ambroxol hydrochloride and salbutamol sulfate
Reddy et al. Evaluation of Phoenix dactylifera fruits for Antiurolithiatic activity
WO2010015253A1 (en) Pharmaceutical composition for nasal application
JP2018065783A (en) Composition and method for treating skin conditions
CN110193010A (en) A kind of preparation and preparation method thereof for alleviating schneiderian membrane symptom
CN104800597A (en) Traditional Chinese medicine composition for treating sphagitis
DE202006011920U1 (en) Pharmaceutical composition for preventive and/or curative topical treatment of e.g. rhinitis, comprises combination of aqueous physiological sodium chloride solution and drug mucus in the form of aqueous extract of Lichen islandicus
CN107349227A (en) A kind of new medicine concocting method
CN108309910A (en) Vigor frost and preparation method thereof
DE202007008818U1 (en) Composition for the treatment of infections
CN110013502A (en) A kind of composition for preventing and treating acute and chronic rhinitis, nasosinusitis
DE102017113203A1 (en) Medical use of potassium hydroxide
CN105796897B (en) Pharmaceutical composition for treating diabetic foot
AT16516U1 (en) nasal spray
CN107714777A (en) A kind of medicine for promoting canker sore recovery from illness
CN104474220B (en) A kind of drug for treating bronchial asthma and preparation method thereof
EP2685960A1 (en) Use of a sprayable composition comprising ambroxol
CN107158078A (en) Special efficacy Chinese herb medicine powder for rhinitis and rhinitis ointment
Iyer et al. Assessment of efficacy, safety and quality of life in postmenopausal women with osteoporosis using salmon calcitonin nasal spray
DE102016125378A1 (en) Composition for the treatment of colds
JP6749563B2 (en) Staphylococcus aureus inhibitor solution, atopic dermatitis treatment solution, cosmetics, cleaning solution and antiseptic solution

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
CB02 Change of applicant information
CB02 Change of applicant information

Address after: No. 1148, Longteng Road, Beihu science and Technology Development Zone, Changchun City, Jilin Province 130000

Applicant after: JILIN HUAEN BIOLOGICAL TECHNOLOGY Co.,Ltd.

Address before: Room 402, 4th floor, C2-1 Beihu Science Park, 3333 Shengbei Street, Beihu Science and Technology Development Zone, Changchun High-tech Development Zone, Jilin Province

Applicant before: JILIN HUAEN BIOLOGICAL TECHNOLOGY Co.,Ltd.

RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20190903